Diabetes News and Research

Latest Diabetes News and Research

Researchers discover first compound to activate enzyme telomerase in human body

Sierra Sciences, in collaboration with TA Sciences, Geron Corporation, PhysioAge, and the Spanish National Cancer Research Center (CNIO), has announced the first compound ever discovered that activates the enzyme telomerase in the human body - a critical prerequisite for technology that could arrest or reverse the aging process in humans.

9 Sep 2010

Performance Plus Marketing wins IMA's Circle of Excellence Award for Victoza campaign

In today's troubled economy, keeping a sales force motivated to perform can be critical to the success of a business. That's why Novo Nordisk turned to Performance Plus Marketing (PPM) of Roswell, GA, to build an incentive program to support the launch of its Diabetes medication, Victoza(R). The campaign's unprecedented success resulted in the Incentive Marketing Association's Circle of Excellence Award for Best Sales Incentive Program.

9 Sep 2010

UC San Diego proferssor awarded 2010 Harvey Prize in human health by Technion

Michael Karin, PhD, Distinguished Professor of Pharmacology and Pathology at the University of California, San Diego School of Medicine has been awarded the 2010 Harvey Prize in human health by the Technion, Israel's premier institute of technology.

9 Sep 2010

WHO forum to review developing country access to life-saving medical devices

More than 350 leading health experts from over 100 countries meet today at a World Health Organization (WHO) forum in Bangkok, Thailand to review new evidence and agree ways to improve developing country access to life-saving medical devices.

9 Sep 2010

DARA BioSciences presents KRN5500 study results at World Congress on Pain

DARA BioSciences announced today that it presented study results from its Phase 2 multicenter, placebo controlled, double-blind, randomized dose escalation study for KRN5500 at the 13th World Congress on Pain held recently in Montreal.

9 Sep 2010

Quercetin and ferulic acid antioxidants aggravate kidney cancer in severely diabetic rats

Scientists are calling for more research on the possibility that some supposedly healthful plant-based antioxidants - including those renowned for their apparent ability to prevent cancer - may actually aggravate or even cause cancer in some individuals. Their recommendation follows a study in which two such antioxidants - quercetin and ferulic acid - appeared to aggravate kidney cancer in severely diabetic laboratory rats. The study appears in ACS' bi-weekly Journal of Agricultural and Food Chemistry.

9 Sep 2010

Canadian Diabetes Association launches campaign to address burden of diabetes in New Brunswick

The Canadian Diabetes Association is urging candidates who are seeking office in the 2010 New Brunswick Provincial Election to take diabetes seriously by committing to a list of priorities that will help improve the lives of New Brunswickers who live with diabetes.

9 Sep 2010

Joslin's Asian American Diabetes Initiative enhances web site

The Asian American Diabetes Initiative at Joslin Diabetes Center has unveiled exciting additions to its web site, http://aadi.joslin.org, offering innovative, interactive and culturally relevant tools for Asian Americans who live with diabetes and their healthcare providers.

9 Sep 2010

Illegal drug usage in older people reduces quality of life: Research

Health and social services are facing a new challenge, as many illicit drug users get older and face chronic health problems and a reduced quality of life. That is one of the key findings of research published in the September issue of the Journal of Advanced Nursing.

9 Sep 2010

Low carbohydrate diet rich in plant-based fats and proteins associated with lower risk of mortality

Those who adhered to a diet low in carbohydrates but rich in animal-based fats and proteins increased their risk of death – especially by cancer, according to a study published in the Annals of Internal Medicine, led by Simmons College nutrition professor Teresa Fung, Sc. D.

9 Sep 2010

Study suggests observing food label guidelines may lead to weight loss

Nutritional science and food marketing has become so sophisticated in recent decades that a trip to the supermarket can require a complete nutritional re-education. The average consumer needs to be on guard against preservatives, added fat, colorings, and calories, false advertising, and sophisticated but misleading labels. Although guidelines for the information of food labels have gotten a bad rap in recent years a new study published in the Journal of Consumer Affairs suggests that observing them may lead to weight loss, especially for women entering their middle years.

9 Sep 2010

Santarus, VeroScience enter agreement to commercialize CYCLOSET drug for type 2 diabetes

Santarus, Inc., S2 Therapeutics, Inc. and VeroScience LLC today announced that they have entered into a distribution and license agreement granting Santarus exclusive rights to manufacture and commercialize CYCLOSET (bromocriptine mesylate) tablets in the U.S.

9 Sep 2010

Researchers demonstrate how insulin prepares cells for glucose uptake

Using high-resolution microscopy, researchers at the National Institutes of Health have shown how insulin prompts fat cells to take in glucose in a rat model. The findings were reported in the Sept. 8 issue of the journal Cell Metabolism.

9 Sep 2010

Insulin may reduce life-threatening bacterial infections in intensive care patients

Treating intensive care patients who develop life-threatening bacterial infections, or septicemia, with insulin potentially could reduce their chances of succumbing to the infection, if results of a new preliminary study can be replicated in a larger study.

9 Sep 2010

PositiveID to sell Health Link personal health record business to Health Plexus

PositiveID Corporation announced today that it has agreed to sell its Health Link personal health record business for $1 million to Health Plexus, LLC. The Company will also retain the right to royalties on future Health Link revenues. Health Link is the Company's web-based personal health record (PHR), which is non-core to the Company's primary HealthID division. HealthID develops and markets unique medical devices, with a focus on diabetes management, and rapid medical testing products.

8 Sep 2010

Liberator Medical Holdings' subsidiary receives 2010 Governor's Business Diversification Award

Liberator Medical Holdings, Inc. today announced its wholly owned subsidiary, Liberator Medical Supply, has received the 2010 Governor's Business Diversification Award in the Business Expansion category.

8 Sep 2010

Late breaking clinical trials in interventional cardiovascular medicine to be presented at TCT 2010

Clinical trials in a variety of areas within interventional cardiovascular medicine that will be presented at TCT 2010 will directly affect the way that people with cardiovascular disease are treated. Breakthroughs in science and medical research, presented exclusively at TCT, will lead to new treatments that are minimally invasive and involve shorter recovery times. Among the topics being covered are stenting in the femoral artery, polymer-free drug-eluting stents, valves and drug-eluting balloons used in angioplasty.

8 Sep 2010

Mary Ann Liebert launches Childhood Obesity journal to promote clinical advances

Publisher Mary Ann Liebert announced the launch of Childhood Obesity to provide physicians, nurses, dietitians, diabetes educators, nutritionists, psychologists, educators and school nurses, community organizers, and policymakers with effective prevention and treatment strategies that promote environmental and policy changes, patient education and motivation tools, and clinical advances in the field.

8 Sep 2010

PLX4032 trial shows high degree of selectivity to achieve tumor shrinkage

Plexxikon today announced publication of key data in this week's edition of Nature demonstrating that the high degree of selectivity of PLX4032 (RG7204) enables substantial RAF/MEK/ERK pathway inhibition, which may be necessary to achieve significant tumor shrinkage and clinical response in patients with BRAF mutant melanoma.

8 Sep 2010

Researchers find blebbistatin chemically inhibits NMII, enhances survival of stem cells

Human pluripotent stem (hPS) cells can generate any given cell type in the adult human body, which is why they are of interest to stem cell scientists working on finding therapies for spinal cord injuries, Parkinson's disease, burns, heart disease, diabetes, arthritis, and other ailments.

8 Sep 2010

Diabetes News and Research

Latest Diabetes News and Research

Researchers discover first compound to activate enzyme telomerase in human body

Performance Plus Marketing wins IMA's Circle of Excellence Award for Victoza campaign

UC San Diego proferssor awarded 2010 Harvey Prize in human health by Technion

WHO forum to review developing country access to life-saving medical devices

DARA BioSciences presents KRN5500 study results at World Congress on Pain

Quercetin and ferulic acid antioxidants aggravate kidney cancer in severely diabetic rats

Canadian Diabetes Association launches campaign to address burden of diabetes in New Brunswick

Joslin's Asian American Diabetes Initiative enhances web site

Illegal drug usage in older people reduces quality of life: Research

Low carbohydrate diet rich in plant-based fats and proteins associated with lower risk of mortality

Study suggests observing food label guidelines may lead to weight loss

Santarus, VeroScience enter agreement to commercialize CYCLOSET drug for type 2 diabetes

Researchers demonstrate how insulin prepares cells for glucose uptake

Insulin may reduce life-threatening bacterial infections in intensive care patients

PositiveID to sell Health Link personal health record business to Health Plexus

Liberator Medical Holdings' subsidiary receives 2010 Governor's Business Diversification Award

Late breaking clinical trials in interventional cardiovascular medicine to be presented at TCT 2010

Mary Ann Liebert launches Childhood Obesity journal to promote clinical advances

PLX4032 trial shows high degree of selectivity to achieve tumor shrinkage

Researchers find blebbistatin chemically inhibits NMII, enhances survival of stem cells

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Diabetes News and Research

Latest Diabetes News and Research

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in